![]()
|
|
||||||||
JBC, Vol. 252, Issue 17, 6076-6081, Sep, 1977
S. Y. Cheng, M. Wilchek, H. J. Cahnmann and J. Robbins
Affinity labeling of human serum prealbumin with N-bromoacetyl-L-thyroxine
(BrAcT4) was used to investigate the binding domain for L-thyroxine (T4) on
prealbumin. Fluorescence titration with 8-anilinonaphthalene-1-sulfonate
revealed a strong and a weak binding site for BrAcT4 (K1 = 1 X 10(8) M-1;
K2 = 1 X 10(6) M-1). The reaction of BrAcT4 with prealbumin to form a
covalent bond was inhibited in the presence of T4 and binding of T4 to
prealbumin was nearly abolished after affinity labeling with BrAcT4.
Affinity labeling with 2 mol of BrAcT4/mol of prealbumin resulted in
covalent binding of 1 mol of ligand. Acid hydrolysis of affinity-labeled
prealbumin gave Nepsilon-carboxymethyllysine and iminodiacetic acid, the
latter being derived from the NH2-terminal glycine. A combination of
analytical procedures, including tryptic digestion after maleylation,
cyanogen bromide cleavage, digestion with yeast protease C, and sequential
Edman degradations, revealed that the Nepsilon-carboxymethyllysine was
derived from lysine-9 and lysine-15 and that the affinity label had
distributed itself among glycine-1, lysine-9, and lysine-15 in a ratio of
29:63:8.
Affinity labeling of human serum prealbumin with N-bromoacetyl-L-thyroxine
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor Endocrinology, April 1, 2002; 143(4): 1190 - 1198. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |